BioCentury
ARTICLE | Clinical News

HaMPCs: Additional Phase IIb data

January 25, 2016 8:00 AM UTC

A single-blind, Chinese Phase IIb trial in 53 patients with OA of the knee showed that 2 intra-articular injections of ReJoin given 3 weeks apart non-significantly reduced WOMAC scores from baseline t...